Department of Endocrinology Diabetes and Metabolism, Evangelismos Hospital, 10676, Athens, Greece.
Hormones (Athens). 2020 Jun;19(2):245-251. doi: 10.1007/s42000-020-00183-0. Epub 2020 Mar 2.
Nonfunctioning pituitary adenomas (NFPAs) are among the commonest benign tumors of the pituitary. Hypopituitarism is frequently present at the time of diagnosis, and this has been attributed to stalk portal vessel compression and/or destruction of normal anterior pituitary cells. The aim of our study was to examine possible factors at diagnosis associated with the presence of hypopituitarism.
We retrospectively evaluated the records of patients with nonfunctioning pituitary macroadenomas from the database of our department. The inclusion criterion was the availability of imaging data regarding the extension of the lesion.
A total of 148 patients (89 men, 60.1%) with nonfunctioning macroadenomas and available imaging data were identified. Mean age at diagnosis was 56.0 ± 14.5 years, and hypopituitarism was found in 66.2%. The maximum diameter of the adenoma, the patient's age at diagnosis, and compression of the optic chiasm were significant factors predicting the presence of hypopituitarism (OR 1.077, p = 0.006; OR 1.025, p = 0.045; and OR 2.893, p = 0.042, respectively). Suprasellar adenomas with extension to adjacent sinuses, although larger than those with only suprasellar extension, did not differ as to the degree of hypopituitarism. Moreover, in suprasellar adenomas, prolactin levels, albeit not independently, were also related to hypopituitarism (OR 1.035, p = 0.045).
In patients with NFPAs, prognostic factors related to increased risk of hypopituitarism are age at diagnosis, size of the adenoma, and most importantly the presence of suprasellar extension. These data accentuate the necessity for surgical decompression in case of suprasellar extension, in order, apart from saving visual acuity, to possibly avoid or reverse hypopituitarism.
无功能垂体腺瘤(NFPAs)是垂体最常见的良性肿瘤之一。在诊断时,常伴有垂体功能减退症,这归因于垂体柄门脉血管受压和/或正常垂体前叶细胞的破坏。我们的研究旨在探讨诊断时与垂体功能减退症相关的可能因素。
我们回顾性地评估了我们科室数据库中无功能垂体大腺瘤患者的记录。纳入标准是有关于病变范围的影像学数据。
共确定了 148 例(89 名男性,60.1%)具有无功能大腺瘤且有可用影像学数据的患者。诊断时的平均年龄为 56.0±14.5 岁,其中 66.2%存在垂体功能减退症。肿瘤最大直径、患者诊断时的年龄和视交叉受压是预测垂体功能减退症存在的显著因素(OR 1.077,p=0.006;OR 1.025,p=0.045;OR 2.893,p=0.042)。虽然鞍上扩展到相邻窦腔的垂体腺瘤比仅鞍上扩展的腺瘤更大,但在垂体功能减退症的严重程度上没有差异。此外,在鞍上腺瘤中,尽管不是独立的,催乳素水平也与垂体功能减退症有关(OR 1.035,p=0.045)。
在 NFPAs 患者中,与发生垂体功能减退症风险增加相关的预后因素是诊断时的年龄、腺瘤大小,最重要的是鞍上扩展。这些数据强调了在存在鞍上扩展的情况下进行手术减压的必要性,除了挽救视力外,还可能避免或逆转垂体功能减退症。